Trials / Completed
CompletedNCT04547712
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate the safety and effectiveness of adaptive DBS (aDBS) for Parkinson's disease.
Detailed description
Prospective single-blind, randomized crossover, multi-center study of aDBS in subjects with Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Adaptive DBS | Subjects for whom both aDBS modes are acceptable will receive Dual and Single Threshold aDBS |
Timeline
- Start date
- 2020-12-14
- Primary completion
- 2023-01-12
- Completion
- 2025-05-02
- First posted
- 2020-09-14
- Last updated
- 2025-07-08
- Results posted
- 2025-07-08
Locations
10 sites across 4 countries: United States, Canada, France, Netherlands
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04547712. Inclusion in this directory is not an endorsement.